Clinical Trial Update: The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Hyoscine-N-butylbromide (Buscopan) in augmented labour among primigravidae has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Labor

Drugs mentioned

• Hyoscine-n-butylbromide (hyoscine butylbromide)

Snippet

Sponsor: National University of Malaysia | Conditions: Labor Long | Phase 4 | Status: COMPLETED